|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06185 CANSINOBIO
Nominal 
28.350 +0.750 (+2.717%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (916,252) | (1,887,599) | 2,014,557 | (469,389) |
| Net Cash from / (used in) Investing Activities | -- | (441,622) | (1,191,955) | (2,531,270) | (182,713) |
| Net Cash from / (used in) Financing Activities | -- | (7,582) | 854,602 | 1,559,922 | 4,923,518 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (1,365,456) | (2,224,952) | 1,043,209 | 4,271,416 |
| Cash & Cash Equivalents at beginning of period | -- | 3,391,268 | 5,455,456 | 4,446,029 | 201,973 |
| Effect of Foreign Exchange Rate Changes | -- | 20,287 | 160,764 | (33,782) | (27,360) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 2,046,099 | 3,391,268 | 5,455,456 | 4,446,029 |
| Remarks: | Real time quote last updated: 05/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -225,373,000 |
| %Change | -73.215% |
| EPS / (LPS) | RMB -0.910 |
| NBV Per Share (¥) | RMB 20.447 |